The University of Chicago Header Logo

Connection

Ralph Weichselbaum to Breast Neoplasms

This is a "connection" page, showing publications Ralph Weichselbaum has written about Breast Neoplasms.
Connection Strength

1.853
  1. Repurposing cephalosporin antibiotics as pro-senescent radiosensitizers. Oncotarget. 2016 Jun 07; 7(23):33919-33.
    View in: PubMed
    Score: 0.176
  2. Cholesterol metabolism and resistance to tamoxifen. Curr Opin Pharmacol. 2012 Dec; 12(6):683-9.
    View in: PubMed
    Score: 0.136
  3. Poly(ADP-ribose) polymerase inhibitor induces accelerated senescence in irradiated breast cancer cells and tumors. Cancer Res. 2010 Aug 01; 70(15):6277-82.
    View in: PubMed
    Score: 0.116
  4. MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer. Cancer Res. 2009 Apr 01; 69(7):2833-7.
    View in: PubMed
    Score: 0.107
  5. MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment. Proc Natl Acad Sci U S A. 2009 Apr 07; 106(14):5837-41.
    View in: PubMed
    Score: 0.106
  6. MUCing around with tumor suppression. Cancer Biol Ther. 2008 Dec; 7(12):1968-9.
    View in: PubMed
    Score: 0.105
  7. An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci U S A. 2008 Nov 25; 105(47):18490-5.
    View in: PubMed
    Score: 0.104
  8. Importance of local control in an era of systemic therapy. Nat Clin Pract Oncol. 2005 Feb; 2(2):60-1.
    View in: PubMed
    Score: 0.080
  9. p50 mono-ubiquitination and interaction with BARD1 regulates cell cycle progression and maintains genome stability. Nat Commun. 2020 10 06; 11(1):5007.
    View in: PubMed
    Score: 0.059
  10. Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells. Nat Commun. 2020 09 14; 11(1):4591.
    View in: PubMed
    Score: 0.059
  11. Low Recombination Proficiency Score (RPS) Predicts Heightened Sensitivity to DNA-Damaging Chemotherapy in Breast Cancer. Clin Cancer Res. 2017 Aug 01; 23(15):4493-4500.
    View in: PubMed
    Score: 0.046
  12. Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer. J Am Chem Soc. 2016 12 28; 138(51):16686-16695.
    View in: PubMed
    Score: 0.046
  13. Breast preservation in stage I and II carcinoma of the breast. The University of Chicago experience. Cancer. 1996 Oct 15; 78(8):1722-30.
    View in: PubMed
    Score: 0.045
  14. Image-Guided Radiotherapy Targets Macromolecules through Altering the Tumor Microenvironment. Mol Pharm. 2016 10 03; 13(10):3457-3467.
    View in: PubMed
    Score: 0.045
  15. Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting? Expert Rev Anticancer Ther. 2016 Jun; 16(6):625-32.
    View in: PubMed
    Score: 0.044
  16. 14q32-encoded microRNAs mediate an oligometastatic phenotype. Oncotarget. 2015 Feb 28; 6(6):3540-52.
    View in: PubMed
    Score: 0.040
  17. Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys. 1994 Aug 30; 30(1):151-60.
    View in: PubMed
    Score: 0.039
  18. Tumor endothelial inflammation predicts clinical outcome in diverse human cancers. PLoS One. 2012; 7(10):e46104.
    View in: PubMed
    Score: 0.034
  19. Cooperative interaction between the MUC1-C oncoprotein and the Rab31 GTPase in estrogen receptor-positive breast cancer cells. PLoS One. 2012; 7(7):e39432.
    View in: PubMed
    Score: 0.033
  20. Prognostic indicators in node-negative early stage breast cancer. Am J Med. 1992 May; 92(5):539-48.
    View in: PubMed
    Score: 0.033
  21. 5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study. Cancer Chemother Pharmacol. 1992; 29(3):178-84.
    View in: PubMed
    Score: 0.032
  22. Predictors of competing mortality in early breast cancer. Cancer. 2010 Dec 01; 116(23):5365-73.
    View in: PubMed
    Score: 0.029
  23. Outcomes in black patients with early breast cancer treated with breast conservation therapy. Int J Radiat Oncol Biol Phys. 2011 Feb 01; 79(2):392-9.
    View in: PubMed
    Score: 0.029
  24. Breast conserving surgery and definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys. 1989 Dec; 17(6):1211-6.
    View in: PubMed
    Score: 0.028
  25. Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer. Oncogene. 2010 Feb 11; 29(6):920-9.
    View in: PubMed
    Score: 0.028
  26. Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation. Cancer. 2008 Nov 01; 113(9):2408-14.
    View in: PubMed
    Score: 0.026
  27. A universal chimeric antigen receptor (CAR)-fragment antibody binder (FAB) split system for cancer immunotherapy. Sci Adv. 2025 Jul 04; 11(27):eadv4937.
    View in: PubMed
    Score: 0.021
  28. Expedition Inspiration Fund for Breast Cancer Research Meeting 2003. Breast Cancer Res Treat. 2003 Jul; 80(2):139-44.
    View in: PubMed
    Score: 0.018
  29. Radioresistance in some human tumor cells conferred in vitro by repair of potentially lethal X-ray damage. Radiology. 1982 Nov; 145(2):511-3.
    View in: PubMed
    Score: 0.017
  30. The differential response of human tumours to fractionated radiation may be due to a post-irradiation repair process. Br J Cancer. 1982 Oct; 46(4):532-7.
    View in: PubMed
    Score: 0.017
  31. Lack of selective killing by steroids in normal and malignant cells. J Cell Physiol. 1980 Jun; 103(3):429-33.
    View in: PubMed
    Score: 0.014
  32. Combination hormonal, chemotherapy and radiotherapy in vitro: implications for therapy in vivo. Int J Radiat Oncol Biol Phys. 1979 Sep; 5(9):1657-61.
    View in: PubMed
    Score: 0.014
  33. Proliferation kinetics of a human breast cancer line in vitro following treatment with 17beta-estradiol and 1-beta-D-arabinofuranosylcytosine. Cancer Res. 1978 Aug; 38(8):2339-42.
    View in: PubMed
    Score: 0.013
  34. Pathogenesis of pleural effusion in carcinoma of the breast. Int J Radiat Oncol Biol Phys. 1977 Sep-Oct; 2(9-10):963-5.
    View in: PubMed
    Score: 0.012
  35. Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation. J Clin Oncol. 1997 Jun; 15(6):2329-37.
    View in: PubMed
    Score: 0.012
  36. CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon Response. Cell Rep. 2017 03 07; 18(10):2373-2386.
    View in: PubMed
    Score: 0.012
  37. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J Natl Cancer Inst. 1996 Dec 04; 88(23):1764-9.
    View in: PubMed
    Score: 0.011
  38. Natural history of node-positive breast cancer: the curability of small cancers with a limited number of positive nodes. J Clin Oncol. 1996 Dec; 14(12):3105-11.
    View in: PubMed
    Score: 0.011
  39. The role of postoperative irradiation in carcinoma of the breast. Cancer. 1976 Jun; 37(6):2682-90.
    View in: PubMed
    Score: 0.011
  40. Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. J Clin Oncol. 1995 May; 13(5):1144-51.
    View in: PubMed
    Score: 0.010
  41. Protease inhibitor antipain reduces nuclear binding of estrogen-receptor complex in MCF-7 breast tumor cells. Carcinogenesis. 1984 Oct; 5(10):1355-7.
    View in: PubMed
    Score: 0.005
  42. Repair of fractionated radiation in plateau phase cultures of human tumor cells and human multicellular tumor spheroids. Radiother Oncol. 1984 Jun; 2(1):41-7.
    View in: PubMed
    Score: 0.005
  43. Effects of estradiol concentration on levels of nuclear estrogen receptors in MCF-7 breast tumor cells. J Steroid Biochem. 1984 Feb; 20(2):605-9.
    View in: PubMed
    Score: 0.005
  44. Work in progress: radioprotection of human breast cancer cells by elevation of intracellular cyclic AMP. Radiology. 1983 Jul; 148(1):289-90.
    View in: PubMed
    Score: 0.004
  45. Effects of serum-free defined medium on MCF-7 cell nuclear estrogen-receptor levels. Mol Cell Endocrinol. 1982 Sep; 28(1):91-98.
    View in: PubMed
    Score: 0.004
  46. X-ray sensitivity of human tumor cells in vitro. Int J Radiat Oncol Biol Phys. 1980 Apr; 6(4):437-40.
    View in: PubMed
    Score: 0.004
  47. Function for p300 and not CBP in the apoptotic response to DNA damage. Oncogene. 1999 Oct 07; 18(41):5714-7.
    View in: PubMed
    Score: 0.003
  48. Superficial doses in treatment of breast with tangential fields using 4MV x-rays. Int J Radiat Oncol Biol Phys. 1977 Jul-Aug; 2(7-8):705-10.
    View in: PubMed
    Score: 0.003
  49. Differing patterns of cytotoxicity of the phorbol ester 12-O-tetradecanoylphorbol 13-acetate in various human cell strains. Carcinogenesis. 1985 Dec; 6(12):1703-8.
    View in: PubMed
    Score: 0.001
  50. Estrogen receptor-mediated cytotoxicity using iodine-125. J Cell Biochem. 1983; 21(1):39-45.
    View in: PubMed
    Score: 0.001
  51. Iodine-125-labelled tamoxifen is differentially cytoxic to cells containing oestrogen receptors. Int J Radiat Biol Relat Stud Phys Chem Med. 1980 Aug; 38(2):197-202.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.